External Quality Control of ER, PR, and HER2 Immunohistochemistry and Continued Need for Optimization
13 Dec 2012

Breast pathology routinely employs immunohistochemistry for the classification and subsequent selection of patients for specific therapies. However, correct interpretation, is dependent on the quality of the staining produced, which can vary enormously between laboratories, and in some instanced show day-to-day variation within the same laboratory. Therefore, it is vital that laboratories not only use standardized staining procedures for ER,PR and HER2 immunohistochemistry but also optimize protocols as required.

Leica Microsystems



Show    per page
1 of 9 Page     1 2 3  ... Next 
Issues of Color in Histology in Medicine20 Nov 2014Read
Instrument performance verification in laser diffraction11 Nov 2014Read
From Daltons to Megadaltons on a Single Mass Spectrometry Platform: UHR-qTOF for Biopharmaceuticals Analysis11 Nov 2014Read
Powering power plants with online particle size analysis11 Nov 2014Read
How to characterize and optimize inkjet inks - Part 111 Nov 2014Read
How to characterize and optimize inkjet inks Part 211 Nov 2014Read
Pharmaceuticals - When size is not enough11 Nov 2014Read
Exploring the role of SEC-MALS in protein and polymer characterization11 Nov 2014Read
Clinical Research of Complex Congenital Brain Malformations by Combined Neuroimaging and Massively Parallel Sequencing Using the TruSight One Sequencing Panel6 Nov 2014Read
Increasing Efficiency of Method Validation with Waters Empower 3 Method Validation Manager (MVM)4 Nov 2014Read